Tarsons Products Ltd. (TARSONS) — Tipsheet

Tarsons profit drops 52% as finance costs and excess pay weigh

Tipsheet Editorial — Fri, 22 May 2026 16:25:25 GMT

Profit collapsed to ₹14.3 crore despite top-line growth, while the company revealed it overpaid its top executives by ₹4.1 crore.

What’s new

Profit slumped to ₹14.3 crore even as revenue grew 7.7% to ₹422.5 crore.
Depreciation surged 54%, compounding the squeeze from higher finance costs.
Management seeks shareholder approval to waive ₹4.1 crore in excess remuneration paid to directors.

Why it matters

The delta between modest revenue growth and a halving of profits is the clearest signal of operational strain. Paying executives in excess of approved limits is an avoidable governance headache for a firm already struggling with margin compression.

What we’re watching

Whether shareholders approve the waiver for the excess executive payouts.
Evidence of margin recovery in the next quarterly results.
Capex efficiency given the sharp jump in depreciation expenses.

The full read

Tarsons Products ended the year with a sharp disconnect between its revenue and its bottom line. While domestic sales helped push revenue up 7.7% to ₹422.5 crore, consolidated net profit fell 52% to ₹14.3 crore. The culprit is a classic combination of scaling costs: depreciation surged 54% during the period, and rising finance costs further drained the residual earnings. Beyond the numbers, the board is dealing with a compliance issue, having paid ₹4.1 crore in remuneration to its managing director and whole-time director that exceeded established limits. It must now ask shareholders to sign off on the error. For a micro-cap, this level of profit erosion is the primary concern, as it suggests the company’s recent capacity expansion has yet to find the volume needed to cover its debt and depreciation load. The shareholder vote on executive pay is now the next hurdle.

Primary source: BSE · NSE

Tarsons Products profit drops 52% as finance and depreciation costs bite

Tipsheet Editorial — Fri, 22 May 2026 16:20:19 GMT

Revenue crept higher while bottom-line profitability collapsed. The company also disclosed an unauthorised ₹4.1 cr payout to its top directors.

What’s new

Consolidated net profit fell to ₹14.3 cr from ₹29.8 cr last year.
Finance costs reached ₹22.5 cr and depreciation hit ₹96.5 cr.
Management paid itself ₹4.1 cr in excess remuneration requiring a shareholder waiver.

Why it matters

The gap between top-line growth and bottom-line erosion is stark. The excess remuneration disclosure suggests poor internal controls on executive pay at a time when shareholders are already seeing profit margins sliced in half.

What we’re watching

Whether shareholders approve the waiver for the excess executive pay.
If the high depreciation cost trajectory from the new facilities moderates in FY27.
The recovery timeline for margins.

The full read

Tarsons Products ended FY26 with a painful disconnect between sales and earnings. While revenue managed a modest 7.7% lift to ₹422.5 crore on the back of domestic demand, the profit line collapsed. Consolidated net profit fell 52% to ₹14.3 crore, dragged down by heavy non-operating charges. Finance costs grew to ₹22.5 crore, and depreciation climbed to ₹96.5 crore, reflecting the burden of recent capital investments. The company further complicated its narrative by disclosing ₹4.1 crore in excess remuneration paid to its managing director and whole-time director. Tarsons must now solicit a shareholder waiver for these payments. Investors are left with a company that is growing its footprint but struggling to convert that scale into cash, all while needing to clean up a governance oversight regarding executive compensation.

Primary source: BSE · NSE

Tarsons Products profits halved as depreciation and interest bite

Tipsheet Editorial — Fri, 22 May 2026 16:11:48 GMT

A 52% drop in net profit to ₹14.3 crore comes alongside a board request to waive ₹4.1 crore in excess executive pay.

What’s new

Consolidated net profit plunged 52% to ₹14.3 crore for FY26.
Higher depreciation of ₹96.5 crore and ₹22.5 crore in finance costs dragged down earnings.
The board is seeking a shareholder waiver for ₹4.1 crore paid in excess managerial remuneration.

Why it matters

Revenue growth of 7.7% is failing to keep pace with the company's rising cost structure. The governance issue regarding executive pay, coupled with the sharp profit decline, suggests management faces difficult questions on both capital allocation and operational efficiency.

What we’re watching

Shareholder reaction to the board's proposal to waive the excess remuneration payout.
The trajectory of finance costs if borrowing levels persist at current heights.
Margin recovery plans following the heavy impact of depreciation on the bottom line.

The full read

Tarsons Products ended FY26 with a significant profitability gap. While revenue grew 7.7% to ₹422.5 crore, the bottom line collapsed 52% to ₹14.3 crore as the company struggled under the weight of higher depreciation and finance costs. These charges hit ₹96.5 crore and ₹22.5 crore respectively, effectively cannibalizing the gains from domestic sales. Adding to the friction is a discovery of excess managerial remuneration; the board has already flagged ₹4.1 crore paid to its managing director and whole-time director. Shareholders must now vote on whether to waive the recovery of these payments. The numbers paint a picture of a company with rising overheads and internal oversight lapses, making the upcoming shareholder vote a key test for management's credibility. What changes from here is whether the company can temper these costs or if they will remain a permanent anchor on earnings.

Primary source: BSE · NSE